Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tecentriq
Pharma
Jazz's almost-withdrawn lung cancer drug shows life
Jazz proposed two phase 3 trials to keep Zepzelca's accelerated approval a few years ago, and one of them has read out positively.
Angus Liu
Oct 15, 2024 10:15am
Exelixis plots FDA prostate cancer filing despite survival miss
Sep 16, 2024 5:00pm
Roche's subcutaneous Tecentriq wins FDA nod after delay
Sep 13, 2024 11:41am
Vabysmo soars as Roche grows through COVID sales declines
Feb 1, 2024 11:36am
Exelixis joins Novartis on FDA waiting list in prostate cancer
Jan 25, 2024 8:00am
BMS's subcutaneous Opdivo measures up to infused version
Oct 19, 2023 11:10am
